TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20381248

Group type: EXPERIMENTAL
Intervention: Metyrapone-induced hypocortisolism
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18694477

Group type: EXPERIMENTAL
Intervention: Direct electronic referral and booking for outpatient surgery (one stop)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional patient pathway (outpatient clinic visit prior to surgery)
Number of subjects: 120
Study: 15866630

Group type: EXPERIMENTAL
Intervention: Daclizumab (1 mg/kg in two doses; preoperatively and on day 14) combined with steroids, mycophenolate mofetil (initial dose of 2 g/d), and tacrolimus (0.1 mg/kg per day).
Number of subjects: 119
Study: 12063522

Group type: EXPERIMENTAL
Intervention: Vaccination with Dermatophagoides pteronyssinus extract encapsulated in liposomes
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo treatment (empty liposomes)
Number of subjects: 55
Study: 9457941

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (Crinone 8%) administered twice daily from day 14, containing 90 mg of micronized progesterone.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intramuscular (IM) progesterone, 100 mg administered from cycle days 15 to 27.
Number of subjects: 72
Study: 7620297

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2234874

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (26 patients)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Ibuprofen (26 patients)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Paracetamol/codeine/caffeine combination (Solpadeine) (25 patients)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Dihydrocodeine (26 patients)
Number of subjects: 103
Study: 376074

Group type: EXPERIMENTAL
Intervention: Ovarian irradiation (2000 rads in 5 days)
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Ovarian irradiation (2000 rads in 5 days) plus prednisone, 7.5 mg daily
Number of subjects: 705

Group type: COMPARATOR
Intervention: No further therapy (Control)
Number of subjects: 705
Study: 31865544

Group type: COMPARATOR
Intervention: CHOICE program offered by itself
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHOICE program offered with GTO implementation support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHOICE program with GTO support
Number of subjects: 0
Study: 29873278

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavior therapy (iCBT) for chronic tinnitus
Number of subjects: 0
Study: 29316383

Group type: EXPERIMENTAL
Intervention: PRE‐RA Plus (PRE‐RA and a one‐on‐one session with a trained health educator)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: PRE‐RA (PRE‐RA alone)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Comparison (standard RA education)
Number of subjects: 238
Study: 23160488

Group type: EXPERIMENTAL
Intervention: omega‐6 once daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: methylphenidate
Number of subjects: 40
Study: 26168277

Group type: EXPERIMENTAL
Intervention: Acute sleep deprivation (TSD)
Number of subjects: 15
Study: 23307203

Group type: EXPERIMENTAL
Intervention: Limbal‐conjunctival autograft transplant
Number of subjects: 224

Group type: COMPARATOR
Intervention: Conjunctival autograft transplant
Number of subjects: 224
Study: 21736785

Group type: EXPERIMENTAL
Intervention: Decaffeinated green tea extract (DGT; 530 mg containing about 400 mg total catechins/capsule, twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decaffeinated green tea extract (DGT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: COMT Val/Met genotype
Number of subjects: 0
Study: 18676202

Group type: EXPERIMENTAL
Intervention: Antegrade cold (4 degrees C) blood cardioplegia (Group A)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Combined antegrade-retrograde cardioplegia (Group B)
Number of subjects: 87
Study: 16298018

Group type: EXPERIMENTAL
Intervention: Context-free implicit evaluations of GM foods using the Go No-Go task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Context-dependent evaluations of GM foods in the context of ordinary and organic foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit attitudes towards GM foods using semantic differential scales
Number of subjects: 0
Study: 14623528

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg
Number of subjects: 0
Study: 11244517

Group type: EXPERIMENTAL
Intervention: Rotational atherectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Excimer laser coronary angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjunct balloon angioplasty
Number of subjects: 0
Study: 9189106

Group type: EXPERIMENTAL
Intervention: Teicoplanin (12 mg/kg intravenously)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 134
Study: 8463989

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 23

Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 23
Study: 2859780

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 121
Study: 30624344

Group type: EXPERIMENTAL
Intervention: Gabapentin (1800 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (placebo or alternative treatment during the crossover)
Number of subjects: 32
Study: 28951525

Group type: EXPERIMENTAL
Intervention: 4 g mixed eicosapentaenoic acid/docosahexaenoic acid in soft-gel capsules
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 4 g mixed eicosapentaenoic acid/docosahexaenoic acid in Smartfish drinks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both omega-3 PUFA formulations
Number of subjects: 22
Study: 27505117

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 53
Study: 26068234

Group type: EXPERIMENTAL
Intervention: High-dose Vitamin D3 supplementation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 74
Study: 23399627

Group type: EXPERIMENTAL
Intervention: Gentamicin sponge and drainage (group A)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Drainage alone (group B)
Number of subjects: 112
Study: 19650808

Group type: EXPERIMENTAL
Intervention: Regional anticoagulation (heparin pre-filter plus post-filter protamine) plus antiaggregation (pre-filter prostacyclin) [Group 1 (G1)]
Number of subjects: 110

Group type: COMPARATOR
Intervention: Systemic heparin anticoagulation without antiaggregation [Group 2 (G2)]
Number of subjects: 110
Study: 18369171

Group type: EXPERIMENTAL
Intervention: NXY-059
Number of subjects: 5028

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5028
Study: 16463861

Group type: EXPERIMENTAL
Intervention: MgSO4 80 mmol/day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 45
Study: 12851303

Group type: EXPERIMENTAL
Intervention: PT-141
Number of subjects: 0
Study: 10357429

Group type: EXPERIMENTAL
Intervention: 24% sucrose solution
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.12% aspartame solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: 24% polycose solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Water
Number of subjects: 60
Study: 7793231

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 3402015

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125 per cent with epinephrine 1:800.000 plus 50 micrograms of fentanyl (Group B)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125 per cent with epinephrine 1:800.000 plus 100 micrograms of fentanyl (Group C)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Bupivacaine 0.125 per cent with epinephrine 1:800.000 (Group A)
Number of subjects: 95
Study: 31074660

Group type: EXPERIMENTAL
Intervention: Self-Management program plus Physical Therapy
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Physical Therapy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control Group (standard medical treatment)
Number of subjects: 66
Study: 31842940

Group type: EXPERIMENTAL
Intervention: Infliximab with methotrexate (IFX+MTX)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Triple therapy (methotrexate, hydroxychloroquine, and sulfasalazine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Methotrexate monotherapy (MTX)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All treatments combined
Number of subjects: 60
Study: 29046405

Group type: EXPERIMENTAL
Intervention: Total potato consumption in PREDIMED (81.9 ± 40.6 g/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total potato consumption in SUN (52.7 ± 33.6 g/d)
Number of subjects: 0
Study: 26639851

Group type: EXPERIMENTAL
Intervention: 0.6% Energy Trans Fatty Acids (TFA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: 0.04% Energy (Control)
Number of subjects: 51
Study: 23092731

Group type: EXPERIMENTAL
Intervention: 0.025% S. flavescens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.050% S. flavescens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.100% S. flavescens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.200% S. flavescens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.400% S. flavescens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (basal diet without S. flavescens)
Number of subjects: 0
Study: 22001182

Group type: EXPERIMENTAL
Intervention: Antecolic reconstruction
Number of subjects: 46

Group type: COMPARATOR
Intervention: Retrocolic reconstruction
Number of subjects: 46
Study: 19092350

Group type: EXPERIMENTAL
Intervention: Intravenous hypocaloric nutrition starting 20 hours before the operation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 22
Study: 21823168

Group type: EXPERIMENTAL
Intervention: Increased dose of olanzapine (OLZ)
Number of subjects: 26
Study: 16202727

Group type: EXPERIMENTAL
Intervention: Laparoscopic adnexectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Open adnexectomy
Number of subjects: 20
Study: 11898975

Group type: EXPERIMENTAL
Intervention: Prior involvement in hiring
Number of subjects: 101

Group type: COMPARATOR
Intervention: No prior involvement
Number of subjects: 101
Study: 9580762

Group type: EXPERIMENTAL
Intervention: High-iron formula (12.7 mg/L of elemental iron)
Number of subjects: 835

Group type: COMPARATOR
Intervention: Low-iron formula (2.3 mg/L of elemental iron)
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: High-iron formula
Number of subjects: 835
Study: 8206405

Group type: EXPERIMENTAL
Intervention: Groshong catheter for intraperitoneal therapy
Number of subjects: 24
Study: 2968268

Group type: EXPERIMENTAL
Intervention: celiprolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: acebutolol
Number of subjects: 30
Study: 12357164

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (n = 16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intravenous analgesia (n = 16)
Number of subjects: 32
Study: 29685179

Group type: EXPERIMENTAL
Intervention: Single dose of oral doxycycline (400 mg) and metronidazole (400 mg)
Number of subjects: 3400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3400
Study: 26661344

Group type: EXPERIMENTAL
Intervention: Patient-performed daily spirometry and positive expiratory pressure (PEP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no spirometry or PEP)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patient education in spirometry and PEP
Number of subjects: 80
Study: 25109873

Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole with antidepressant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bupropion
Number of subjects: 0
Study: 22544471

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 6
Study: 21119408

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (820 nm, 3 J/cm2, 300-mW output power), applied 2 times per week for a total of 10 sessions.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Occlusal splints, worn 24 hours a day for 3 months.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Low-level laser and Occlusal splints)
Number of subjects: 40
Study: 18381578

Group type: EXPERIMENTAL
Intervention: L-thyroxine treatment
Number of subjects: 11
Study: 16169561

Group type: EXPERIMENTAL
Intervention: IFN beta‐1a, 44 mcg subcutaneously (sc) three times weekly (tiw) (Rebif)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IFN beta‐1a, 30 mcg intramuscularly (im) once weekly (qw) (Avonex)
Number of subjects: 0
Study: 11755292

Group type: EXPERIMENTAL
Intervention: Growth hormone (4 IU subcutaneously every other day for three months)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11720604

Group type: EXPERIMENTAL
Intervention: Candesartan 32 mg once daily
Number of subjects: 332

Group type: COMPARATOR
Intervention: Losartan 100 mg once daily
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 332
Study: 8546999

Group type: EXPERIMENTAL
Intervention: Oral liarozole at a daily dose of 75 mg b.i.d. for 12 weeks, with possible increase to 150 mg b.i.d. after 1 month if no improvement
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Oral liarozole
Number of subjects: 31
Study: 2132454

Group type: EXPERIMENTAL
Intervention: Experimental rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional mouthwash
Number of subjects: 0
Study: 381957

Group type: EXPERIMENTAL
Intervention: Ticrynafen (250‐‐500 mg/day)
Number of subjects: 526

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (50‐‐100 mg/day)
Number of subjects: 526
Study: 31544279

Group type: EXPERIMENTAL
Intervention: SRCfield
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CRfield
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: SRCdyna
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CRdyna
Number of subjects: 17
Study: 31547286

Group type: EXPERIMENTAL
Intervention: Noticing urban nature
Number of subjects: 582

Group type: COMPARATOR
Intervention: Built spaces (active control)
Number of subjects: 582
Study: 27470470

Group type: EXPERIMENTAL
Intervention: Reach-to-Grasp training (14 one-hour therapist visits over 6 weeks, plus one hour self-practice per day)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual care (10.5 therapist visits, 38.6 minutes of arm therapy, 16 repetitions of functional tasks per visit)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Reach-to-Grasp training
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study: 26177655

Group type: EXPERIMENTAL
Intervention: JNJ-42847922 (3-30 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JNJ-42847922
Number of subjects: 0
Study: 23920052

Group type: EXPERIMENTAL
Intervention: Laser acupuncture to LR8
Number of subjects: 16

Group type: COMPARATOR
Intervention: Needle acupuncture to LR8
Number of subjects: 16
Study: 21282343

Group type: EXPERIMENTAL
Intervention: Bilio-pancreatic diversion (BPD)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional therapy (control)
Number of subjects: 110
Study: 19255229

Group type: EXPERIMENTAL
Intervention: High-flexion cruciate-retaining knee prosthesis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard cruciate-retaining knee prosthesis
Number of subjects: 100
Study: 16459124

Group type: EXPERIMENTAL
Intervention: Physical rehabilitation programme using auditory cues
Number of subjects: 9

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 9
Study: 14581115

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.05 or 0.1 microg/kg/min)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Naloxone (0.01 mg/kg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 13
Study: 11061771

Group type: EXPERIMENTAL
Intervention: Cisapride (0.2 mg/kg/dose 3 times/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no cisapride)
Number of subjects: 120
Study: 8659936

Group type: EXPERIMENTAL
Intervention: 37 degrees C, 90% RH
Number of subjects: 21

Group type: COMPARATOR
Intervention: 20 degrees C, 30% RH
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Allergen challenge after both conditions
Number of subjects: 21
Study: 1454835

Group type: EXPERIMENTAL
Intervention: Tacrine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 6512867

Group type: EXPERIMENTAL
Intervention: Standard Couple Therapy
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Group Therapy
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Minimal Contact Bibliotherapy (self‐help)
Number of subjects: 23
Study: 31687394

Group type: EXPERIMENTAL
Intervention: Whole-Body Electromyostimulation (WB-EMS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional Training (CT)
Number of subjects: 110
Study: 30305160

Group type: EXPERIMENTAL
Intervention: Lumen-apposing metal stents (LAMS)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Double pigtail plastic stents (DPPS)
Number of subjects: 256
Study: 25786348

Group type: EXPERIMENTAL
Intervention: Newborn excess weight loss (EWL) defined as loss of >10% of birthweight
Number of subjects: 1107

Group type: EXPERIMENTAL
Intervention: Mothers of infants with EWL
Number of subjects: 1107

Group type: COMPARATOR
Intervention: Mothers of infants without EWL
Number of subjects: 1107

Group type: EXPERIMENTAL
Intervention: Mothers with milk supply concern at 2 weeks
Number of subjects: 1107
Study: 24844747

Group type: EXPERIMENTAL
Intervention: 15 mg oral tiagabine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22825365

Group type: EXPERIMENTAL
Intervention: Larazotide acetate (0.25, 1, 4, or 8 mg)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Larazotide acetate
Number of subjects: 86
Study: 20116087

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg) and acetyl salicylic acid (100 mg) after coronary stenting for myocardial infarction
Number of subjects: 66
Study: 18050208

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg twice weekly
Number of subjects: 682

Group type: COMPARATOR
Intervention: Methotrexate ≤20 mg weekly
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Combination of etanercept and methotrexate
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 682
Study: 16181235

Group type: EXPERIMENTAL
Intervention: LGH (0.10 mg/day)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: SGH (mean dose 0.48 mg/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 25
Study: 12173120

Group type: EXPERIMENTAL
Intervention: Ertapenem
Number of subjects: 540

Group type: COMPARATOR
Intervention: Piperacillin-tazobactam
Number of subjects: 540
Study: 9849172

Group type: EXPERIMENTAL
Intervention: PUVA baths (15 minutes in tap water and Ultra MOP)
Number of subjects: 45
Study: 8021040

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer dentifrice
Number of subjects: 194

Group type: COMPARATOR
Intervention: Triclosan/soluble pyrophosphate dentifrice
Number of subjects: 194

Group type: COMPARATOR
Intervention: Triclosan/zinc citrate dentifrice
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 194
Study: 2812979

Group type: EXPERIMENTAL
Intervention: Bicycle ergometer exercise at 30% heart-rate reserve
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bicycle ergometer exercise at 60% heart-rate reserve
Number of subjects: 24
Study: 1036963

Group type: EXPERIMENTAL
Intervention: Metamizol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketobemidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30476335

Group type: EXPERIMENTAL
Intervention: Intervention tools (e.g., prompts and standing desks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change in number of tools
Number of subjects: 0
Study: 31009470

Group type: EXPERIMENTAL
Intervention: Acupuncture (5 sessions by an acupuncturist midwife)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 199
Study: 28598913

Group type: EXPERIMENTAL
Intervention: 30% xenon adjuvant to propofol anesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 50
Study: 27589584

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass
Number of subjects: 2

Group type: COMPARATOR
Intervention: Very-low-calorie diet
Number of subjects: 2
Study: 24456128

Group type: COMPARATOR
Intervention: Breast irradiation (50 Gy in 25 fractions)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Biologically equivalent dose (BED) Gy3 ≥ 80 Gy
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: BED Gy3 ≥ 80 Gy
Number of subjects: 688
Study: 23016867

Group type: EXPERIMENTAL
Intervention: Metronidazole (MTZ) 400 mg thrice a day (TID) for 14 days
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Metronidazole + Amoxicillin (MTZ+AMX) 500 mg TID for 14 days
Number of subjects: 118

Group type: COMPARATOR
Intervention: Chlorhexidine 0.12% rinsed twice a day (BID) for 2 months
Number of subjects: 118

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) only
Number of subjects: 118
Study: 18801487

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) for 24 weeks
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) and Placebo
Number of subjects: 134
Study: 18004925

Group type: EXPERIMENTAL
Intervention: UltraEZ potassium nitrate desensitizer
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: BisBlock oxalate desensitizer
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (untreated enamel)
Number of subjects: 45
Study: 15347540

Group type: EXPERIMENTAL
Intervention: Epley maneuver
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo maneuver
Number of subjects: 22